Literature DB >> 5395692

[Experiences with the new serotonin antagonist BC-105 (Sandomigran) in the treatment of migraine].

J Schär.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5395692

Source DB:  PubMed          Journal:  Praxis        ISSN： 0369-8394


× No keyword cloud information.
  3 in total

1.  Low-dose clonidine: a review of its therapeutic efficacy in migraine prophylaxis.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Clinical observations with pizotifene (Sandomigran) in the treatment of nonmigrainous depressed women.

Authors:  C M Banki
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-03-07

Review 3.  Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.

Authors:  T M Speight; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.